S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6992 −0.02%
PRE-MKT · 05:55 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead

WVE

Wave Life Sciences, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
2.77
−0.07 −2.46%
USD · close Nov 18

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $545.8MP/E —DIV YIELD —FCF YIELD -35.39%REV TTM —NET INCOME −$202.5MNET CASH —52W 2.77 – 21.31SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 62 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2026 · Jun 30$2.3M−73.9%—−$73.8M−$69.4M—-0.34−$53.6M$884K−$54.5MJul 30
Q1 2026 · Mar 31$38.2M+316.9%—−$31.3M−$26.1M—-0.13−$59.6M$438K−$60MJul 30
Q4 2025 · Dec 31derived———−$56.5M−$53.2M−281.8%-0.29−$33.8M−$1K−$33.8MFeb 26
Q3 2025 · Sep 30———−$56.4M−$53.9M—-0.32−$44.7M$248K−$44.9MNov 10
Q2 2025 · Jun 30$8.7M−55.8%—−$52.8M−$50.5M—-0.31−$46M$306K−$46.3MJul 30
Q1 2025 · Mar 31$9.2M−26.8%—−$49.8M−$46.9M—-0.29−$63M$165K−$63.2MJul 30
Q4 2024 · Dec 31derived———$23M$29.3M—0.27−$43.6M$86K−$43.7MFeb 26
Q3 2024 · Sep 30———−$63.9M−$61.8M−951.9%-0.47−$46.5M$383K−$46.9MNov 10
Q2 2024 · Jun 30$19.7M——−$35M−$32.9M—-0.25−$27.5M$52K−$27.5MNov 10
Q1 2024 · Mar 31$12.5M——−$34.5M−$31.6M—-0.24−$33.4M$417K−$33.8MNov 10
Q4 2023 · Dec 31derived$29.1M——−$18.7M−$16.3M—-0.15−$33.2M$356K−$33.6MFeb 26
Q3 2023 · Sep 30$49.2M——$4.4M$7.3M—0.07−$34.5M$198K−$34.7MNov 12

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$42.7M—−$215.4M−$204.4M-478.3%-1.21−$187.5M$718K−$188.2M——
FY2024 · to Dec 31$108.3M—−$110.4M−$97M-89.6%-0.70−$151M$938K−$152M——
FY2023 · to Dec 31$113.3M—−$68M−$57.5M-50.8%-0.54−$19.4M$1.1M−$20.5M——
FY2022 · to Dec 31$3.6M—−$162.7M−$161.8M-4434.7%-2.05−$127.8M$1.4M−$129.1M——
FY2021 · to Dec 31$41M—−$127M−$122.2M-298.4%-2.36−$89M$560K−$89.6M——
FY2020 · to Dec 31$20.1M—−$153.4M−$149.9M-746.7%-3.82−$116M$1.3M−$117.3M——

Every number comes from Wave Life Sciences, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch WVE. Know when insiders buy.
One email the day a filing lands. Free.